Your search for oral corticosteroids returned 2 results

Subcutaneous dupilumab significantly reduced the use of oral corticosteroids in patients with corticosteroid-dependent severe asthma.

Peak expiratory flow increases were greater with benralizumab than placebo in patients with severe eosinophilic asthma.